Priority claimed from 04/02/2020; Application No. : 018191654 ;European Union
Goods or services claimed
IR DIVISION Empty gelatin and vegan capsules for pharmaceutical use; orally dissolvable capsules.
Similar marks in class 5, same issue
- LAGIMMU Priority claimed from 01/04/2020; Application No. : 88856495 ;United States of America similar · Bristol-Myers Squibb Company
- Priority claimed from 20/01/2023; Application No. : UK00003870096 ;United Kingdom similar · [International Registration No. : 1722665]
- NUKARIO Priority claimed from 27/04/2023; Application No. : 97910214 ;United States of America similar · Genzyme Corporation
- ORYPKI Priority claimed from 27/04/2023; Application No. : 97910219 ;United States of America similar · Genzyme Corporation
- Priority claimed from 08/04/2023; Application No. : 795890 ;Switzerland similar · [International Registration No. : 1736373]
- Priority claimed from 17/07/2020; Application No. : 1421409 ;Benelux similar · [International Registration No. : 1565833]
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for Priority claimed from 04/02/2020; Application No. : 018191654 ;European Union
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.